​

IQVIA (IQV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IQV Stock Forecast

IQVIA (IQV) stock forecast, based on 44 Wall Street analysts, predicts a 12-month average price target of $184.50, with a high of $225.00 and a low of $160.00. This represents a -6.71% decline from the last price of $197.76.

$160 $179 $198 $217 $236 $255 High: $225 Avg: $184.5 Low: $160 Last Closed Price: $197.76

IQV Stock Rating

IQVIA stock's rating consensus is Buy, based on 44 Wall Street analysts. The breakdown includes 1 Strong Buy (2.27%), 32 Buy (72.73%), 10 Hold (22.73%), 1 Sell (2.27%), and 0 Strong Sell (0.00%).

Buy
Total 44 1 10 32 1 Strong Sell Sell Hold Buy Strong Buy

IQV Price Target Upside V Benchmarks

TypeNameUpside
StockIQVIA-6.71%
SectorHealthcare Stocks 19.91%
IndustryDiagnostics & Research Stocks15.20%
IdeaSaaS Stocks List0.87%

Price Target Trends

1M3M12M
# Anlaysts1412
Avg Price Target$225.00$192.00$222.95
Last Closing Price$197.76$197.76$197.76
Upside/Downside13.77%-2.91%12.74%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 252147--23
Jun, 253147--24
May, 253157--25
Apr, 255155--25
Mar, 257145--26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 25, 2025Ann HynesMizuho Securities$225.00$199.1712.97%13.77%
May 23, 2025Jamie ClarkRedburn Partners$188.00$137.0037.23%-4.94%
May 15, 2025Ann HynesMizuho Securities$190.00$140.4335.30%-3.92%
May 07, 2025Luke SergottBarclays$165.00$146.2012.86%-16.57%
Apr 25, 2025Sidharth SahooHSBC$160.00$150.286.47%-19.09%
Nov 04, 2024Jaliendra SinghTruist Financial$265.00$210.1926.08%34.00%
Oct 31, 2024Elizabeth AndersonEvercore ISI$235.00$205.8214.18%18.83%
Oct 29, 2024Sean DodgeRBC Capital$270.00$217.5424.12%36.53%
Oct 16, 2024Justin BowersDeutsche Bank$270.00$232.9815.89%36.53%
Oct 14, 2024Jamie ClarkRedburn Partners$276.00$229.2620.39%39.56%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 23, 2025Cowen & Co.BuyBuyhold
May 22, 2025CitigroupNeutralNeutralhold
Apr 25, 2025HSBCHolddowngrade
Feb 03, 2025BTIGBuyNeutraldowngrade
Dec 19, 2024StephensOverweightinitialise
Nov 01, 2024Cowen & Co.BuyBuyhold
Nov 01, 2024BTIGBuyBuyhold
Oct 29, 2024RBC CapitalOutperformOutperformhold
Oct 16, 2024Deutsche BankBuyBuyhold
Sep 04, 2024RBC CapitalOutperformUnderperforminitialise

Financial Forecast

EPS Forecast

$0 $4 $8 $12 $16 $20 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.46$5.05$5.82$7.39$7.57----
Avg Forecast$6.31$8.91$10.15$10.19$11.12$11.92$13.28$14.73$16.44
High Forecast$6.43$9.08$10.36$10.21$11.17$12.16$15.49$16.25$16.73
Low Forecast$6.23$8.79$9.99$10.17$11.10$11.61$11.72$12.58$15.94
Surprise %-76.86%-43.32%-42.66%-27.48%-31.92%----

Revenue Forecast

$11B $13B $15B $16B $18B $20B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.36B$13.87B$14.41B$14.98B$15.40B----
Avg Forecast$11.20B$13.83B$14.38B$14.91B$15.38B$16.04B$17.01B$18.04B$19.49B
High Forecast$11.35B$14.02B$14.61B$14.92B$15.39B$16.21B$17.01B$18.06B$19.76B
Low Forecast$11.08B$13.68B$14.21B$14.90B$15.35B$15.68B$17.01B$18.02B$19.03B
Surprise %1.44%0.32%0.20%0.49%0.18%----

Net Income Forecast

$0 $700M $1B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$279.00M$966.00M$1.09B$1.36B$1.37B----
Avg Forecast$268.05M$896.18M$1.17B$1.36B$2.07B$2.21B$2.54B$2.69B$3.06B
High Forecast$329.82M$1.08B$1.41B$1.63B$2.08B$2.27B$2.89B$3.03B$3.12B
Low Forecast$206.28M$716.94M$938.68M$1.09B$2.07B$2.16B$2.18B$2.34B$2.97B
Surprise %4.09%7.79%-7.02%--33.80%----

IQV Forecast FAQ

Is IQVIA stock a buy?

IQVIA stock has a consensus rating of Buy, based on 44 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 32 Buy, 10 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that IQVIA is a favorable investment for most analysts.

What is IQVIA's price target?

IQVIA's price target, set by 44 Wall Street analysts, averages $184.5 over the next 12 months. The price target range spans from $160 at the low end to $225 at the high end, suggesting a potential -6.71% change from the previous closing price of $197.76.

How does IQVIA stock forecast compare to its benchmarks?

IQVIA's stock forecast shows a -6.71% downside, underperforming the average forecast for the healthcare stocks sector (19.91%) and underperforming the diagnostics & research stocks industry (15.20%), trailing the SaaS Stocks List (0.87%) investment idea.

What is the breakdown of analyst ratings for IQVIA over the past three months?

  • July 2025: 8.70% Strong Buy, 60.87% Buy, 30.43% Hold, 0% Sell, 0% Strong Sell.
  • June 2025: 12.50% Strong Buy, 58.33% Buy, 29.17% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 12.00% Strong Buy, 60.00% Buy, 28.00% Hold, 0% Sell, 0% Strong Sell.

What is IQVIA’s EPS forecast?

IQVIA's average annual EPS forecast for its fiscal year ending in December 2025 is $11.92, marking a 57.46% increase from the reported $7.57 in 2024. Estimates for the following years are $13.28 in 2026, $14.73 in 2027, and $16.44 in 2028.

What is IQVIA’s revenue forecast?

IQVIA's average annual revenue forecast for its fiscal year ending in December 2025 is $16.04B, reflecting a 4.09% increase from the reported $15.4B in 2024. The forecast for 2026 is $17.01B, followed by $18.04B for 2027, and $19.49B for 2028.

What is IQVIA’s net income forecast?

IQVIA's net income forecast for the fiscal year ending in December 2025 stands at $2.21B, representing an 61.26% increase from the reported $1.37B in 2024. Projections indicate $2.54B in 2026, $2.69B in 2027, and $3.06B in 2028.